Market Place
Sourcing Support
Innovent Ph 2 Of Picankibart In Ulcerative Colitis Met Endpoint
16 Oct 2024 //
PR NEWSWIRE
Enforcement Report - Week of March 29, 2023
29 Mar 2023 //
FDA
XELSTRYM transdermal system, CII, to be revealed as available soon at APSARD
10 Jan 2023 //
PR NEWSWIRE
Enforcement Report - Week of December 7, 2022
07 Dec 2022 //
FDA
Noven To Participate In Annual International Conference On Adhd (Chadd)
10 Nov 2022 //
PRNEWSWIRE
Noven To Present Poster Data At The AACAP & CACAP Conference
11 Oct 2022 //
PRNEWSWIRE
Enforcement Report - Week of July 6, 2022
06 Jul 2022 //
FDA
Enforcement Report - Week of August 25, 2021
25 Aug 2021 //
FDA
Noven to Present Pivotal Study Results for Investigational Dextroamphetamine
27 Apr 2021 //
BUSINESSWIRE
Enforcement Report - Week of March 10, 2021
10 Mar 2021 //
FDA
Noven Submits New Drug Application for Investigational Dextroamphetamine
22 Feb 2021 //
BUSINESSWIRE
Noven Submits New Drug Application for Investigational Dextroamphetamine
22 Feb 2021 //
BUSINESSWIRE
Enforcement Report - Week of April 29, 2020
29 Apr 2020 //
FDA
SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch
13 Apr 2020 //
BUSINESSWIRE
Enforcement Report - Week of March 25, 2020
25 Mar 2020 //
FDA
FDA Approves Noven Pharmaceuticals’ Transdermal Patch for Schizophrenia
15 Oct 2019 //
BIOSPACE
Categorical Response &Clinical Relevance as Assessed in a PhIII Study of HP-3070
20 May 2019 //
BUSINESSWIRE
Enforcement Report - Week of October 3, 2018
03 Oct 2018 //
FDA
Enforcement Report - Week of May 16, 2018
16 May 2018 //
FDA
Farxiga® (Estradiol ): Noven Pharmaceuticals, v. Amneal Pharmaceuticals
08 May 2018 //
PATENT LITIGATION
Enforcement Report - Week of April 25, 2018
25 Apr 2018 //
FDA
Enforcement Report - Week of September 27, 2017
28 Sep 2017 //
FDA
Enforcement Report - Week of July 5, 2017
05 Jul 2017 //
FDA
Patent:Novartis AG v. Noven Pharmaceuticals Inc.
05 Apr 2017 //
PATENT DOC
FDA issues Noven another warning letter for factory that produces ADHD patches
23 Aug 2016 //
FIERCE PHARMA
Noven Pharmaceuticals, Inc. Receives FDA Warning Letter
05 Aug 2016 //
FDA
Noven ADHD patches in short supply after recall
20 Jul 2016 //
FIERCE PHARMA
Noven Pharma, Hisamitsu Pharma sue Mylan on generic Minivelle
06 May 2015 //
PHARMA BIZ
Up and Down the Ladder: The Latest Comings & Goings at Orexigen, Pfizer and…
04 Apr 2015 //
PHARMALOT
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.